Syngene announces Q1 FY20 results
Revenue up four per cent to Rs 441 crores, Profit After Tax increases nine per cent to Rs 72 crores. Further, Dr Mahesh Bhalgat…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Cipla USA acquires anti-infective ZEMDRI( IV Plazomicin)
Plazomicin is a IV aminoglycoside with once-daily dosing for cUTI in adults, with proven activity against certain drug-resistant…
Dr Reddy’s launches insomnia treatment tablets in US
The company has launched Ramelteon tablets in the strength of 8 mg after getting approval from USFDA
International Freight Logistics Network launches network for healthcare, pharma logistics
The network will utilise expertise, local know-how found within its membership to fullest extent
Malaria resistance to first-line antimalarial drugs spreading rapidly: The Lancet
Researchers from Wellcome Sanger Institute and University of Oxford found that descendants of one multi-drug resistant malaria…
Zydus Cadila launches insomnia drug in the US market
The drug will be manufactured at group's formulations manufacturing facility at SEZ, Ahmedabad
Lonza expands its bioconjugation facility in Visp, Switzerland
Lonza’s expansion will meet development, manufacturing needs of pharma and biotech companies developing a new generation of…
Government takes steps for vaccination of new borns
The steps tend to create awareness among parents of newborns about the importance of vaccination
AYUSH GRID Project to digitise AYUSH healthcare delivery
This project will develop a network of people, knowledge and technology for radical, sustainable and wholesome transformation of…
GSK Pharmaceuticals’ revenue grows at seven per cent in Q1
For the quarter ended 30th June, 2019, GlaxoSmithKline Pharmaceuticals' Profit After Tax grew at 28 per cent